Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China OKs Hypertension Diagnostics' cardiovascular profiler:

This article was originally published in Clinica

Executive Summary

Hypertension Diagnostics has gained the go-ahead in China to market its CVProfilor DO-2020 cardiovascular profiling system for noninvasively screening, diagnosing and monitoring the treatment of patients with cardiovascular disease. The approval comes after the company's exclusive Chinese distributor - ShenZhen Filiale ShenYong Medical-Pharmacal Co - received the okay from the Chinese State Drug Administration to import and market the system. Some 40% of deaths in China result from heart disease or strokes, says St Paul, Minnesota-based Hypertension Diagnostics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060778

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel